In February 2016 legislation (Narcotics Amendment Bill 2016) to legalise medical cannabis in Australia passed through federal Australian parliament in record time. It was supported by all sides of politics. This means as at 1 November 2016 Australian patients with certain serious medical conditions and under strict controls will be able to access these products through medical professionals.
Cannabis has been used as a medicine since ancient times. In modern history it was used extensively in pharmacy formulations in the early 19th century.
Cannabis used as a medicine has made a resurgence in recent years and is now legal in a number of parts of the world. Whilst anecdotal cases are plentiful scientific studies are still being undertaken to determine the effectiveness in certain disease states. The main ones we are studying below:
Medical Cannabis Research Australia was established in December 2016 by Paul and Sharlene Mavor and Tony Hume.
Paul Mavor is a pharmacist and has practiced for over 26 years in WA and owned a number of pharmacies. He has an interest in the pharmacokinetics of different cannabis dosage forms.
Sharlene Mavor is a medical scientist with majors in Microbiology, Virology and Biotechnology. She has worked in a number of laboratories both in Western Australia and in the UK. Sharlene has a particular interest in different cannabis strains, potency and purity testing and extraction methods.
Tony Hume is an experienced fund raiser and has a diverse background in education, health and philanthropy. He is a graduate of the Australian Institute of Company Director’s course and is accredited as a Certified Fundraising Executive (CFRE) world-wide. Tony also is an Independent Director for the Yinhawangka people in the Eastern Pilbara region. He is passionate about positive community impact and making connections in the community to maximise peoples’ opportunities.
Medical Cannabis Research Australia is committed to improve the lives of Australian persons and families by reducing the suffering, prevalence and impact of a variety of diseases through the use of medical cannabis. This will be achieved with a focus on clinical trials and ethical supply of medical cannabis. Research will be conducted to support and promote public awareness for the use of medical cannabis including education for clinical practitioners with new treatment options, both locally and globally for their patients. We aim to educate and advise health professionals, patients, their families and carers in the use of medical cannabis through media, education and fund raising campaigns and further cooperate with government and likeminded organisations in order to advance the research, treatments, equity and quality of life which can be assisted with the use of medical cannabis.Donate Now